Abiochem Biotechnology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Abiochem Biotechnology Co., Ltd. - overview
Established
2015
Location
Shanghai, -, China
Primary Industry
Biotechnology
About
Founded in 2015 and based in Shanghai, China, Abiochem Biotechnology Co. , Ltd. is a high-tech company that engages in the development of biocatalysis and synthetic biology processes based on genetic & enzyme engineering technologies to apply them in commercial scale production. In July 2025, Abiochem Biotechnology Co.
, Ltd. raised CNY 450 million in Series D funding from new investor Guotou Juli Investment Management. The company provides biocatalysis and synthetic biology methods that are widely used in pharmaceuticals, health products, pesticides, and other fields, contributing to the promotion and development of green chemistry. The company generates revenue through the research and development of biocatalysis, synthetic biology methods and offers other services for biocatalysis technologies.
Current Investors
HighLight Capital, Beyond Capital, Addor Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy
Website
www.abiochem.cn
Verticals
Manufacturing
Company Stage
Series D
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.